Redx is a UK biotechnology Group whose shares are traded on AIM ( AIM:REDX ). Redx is focused on creating and developing first, or potentially best in class drugs, in specific areas of cancer and fibrosis that address significant unmet medical need. Redx has an in-house discovery team with proven world-class chemistry capabilities.
Member count: 51-200
Total raised: $3.060882M
Founded date: 2010
Investors 2
| Date | Name | Website |
| 25.02.2021 | Sofinnova ... | sofinnovap... |
| - | Perscitus ... | perscitusl... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.11.2010 | - | $3.060882M | - | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 17.06.2021 | REDX PHARM... | By Adria Calatayud Redx Pharm... | - | - | marketscre... |
| 24.12.2020 | REDX PHARM... | THIS ANNOUNCEMENT, INCLUDING T... | - | - | marketscre... |
| 24.12.2020 | Redx Pharm... | THIS ANNOUNCEMENT, INCLUDING T... | - | - | marketscre... |
| 27.04.2018 | Ex-AstraZ... | Lisa Anson → Redx $REDX has ... | - | Amber Tong | endpts.com... |
| 30.03.2017 | CARB-X dis... | Launched in mid-2016, CARB-X s... | - | - | medcitynew... |
| 13.11.2010 | Redx Pharm... | Last October, Redx Pharma Ltd,... | funding S... | - | finsmes.co... |
| - | CARB-X dis... | CARB-X is making it rain. The... | - | - | medcitynew... |